Moreover, for investigating the clinical indices of CHEK2 in HCC, we selected TCGA, ICGC, and GAO et al. cohorts and we found higher CHEK2 group predicted poor overall survival rates than the lower CHEK2 group (Fig. 1F–H). Here, CHEK2 is linked to hepatocellular carcinoma.